Spero Therapeutics (SPRO) Deferred Taxes (2016 - 2018)
Spero Therapeutics posted quarterly Deferred Taxes of $645000.0 for Q4 2018, up 2054.55% year-on-year from $29936.7 in Q4 2017, and up 2115.62% on a QoQ basis from -$32000.0 in Q3 2018.
Spero Therapeutics (SPRO) has 3 years of Deferred Taxes data on file, last reported at $645000.0 in Q4 2018.
- For the quarter ending Q4 2018, Deferred Taxes rose 2054.55% year-over-year to $645000.0; the trailing twelve-month figure through Dec 2018 stood at $554000.0 (up 532.81% YoY), and the FY2018 full-year result was $554000.0, up 532.81% from the prior year.
- Deferred Taxes for Q4 2018 stood at $645000.0, up from -$32000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $645000.0 in Q4 2018 and bottomed at -$497000.0 in Q1 2017.
- The 3-year median for Deferred Taxes is -$32000.0 (2018), against an average of $44222.2.
- Peak annual rise in Deferred Taxes reached 2054.55% in 2018, while the deepest fall reached 105.29% in 2018.
- A 3-year view of Deferred Taxes shows it stood at -$28000.0 in 2016, then decreased by 17.86% to -$33000.0 in 2017, then surged by 2054.55% to $645000.0 in 2018.
- The last three Deferred Taxes figures came in at $645000.0 (Q4 2018), -$32000.0 (Q3 2018), and -$23000.0 (Q2 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 645,000.00 |
| Sep 30, 2018 | -32,000.00 |
| Jun 30, 2018 | -23,000.00 |
| Mar 31, 2018 | -36,000.00 |
| Dec 31, 2017 | -33,000.00 |
| Sep 30, 2017 | -33,000.00 |
| Jun 30, 2017 | 435,000.00 |
| Mar 31, 2017 | -497,000.00 |
| Dec 31, 2016 | -28,000.00 |